Artificial intelligence is increasingly shaping biopharma innovation and clinical practice. From AI models diagnosing structural heart disease via ECG, to spatial transcriptomics projects combining AI analysis with high-throughput molecular data for cancer and inflammatory diseases, AI tools are enhancing research capabilities and patient care. Patient perspectives indicate broad acceptance if AI supports rather than replaces human clinicians.